Supply Chain Intern (Summer 2026) at Clairo

St Joseph, Missouri, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

NoVisa

Automotive, Manufacturing, MarineIndustries

Requirements

Currently enrolled as a full-time student at an accredited U.S. college or university
Pursuing an undergraduate degree in Supply Chain or related field
Authorized to work for any employer in the US without need for sponsorship, now or in the future
Available for Summer 2026 (up to 40 hours per week)
Able to work on-site at manufacturing facility in St. Joseph, MO

Responsibilities

Increase DOH (Days of Inventory on Hand)
Increase run sizes
Improve accuracy
Assist with Inventory Reconciliations
Eliminate wet plates
Decrease scrap cost
Learn to release production schedules
Create changeover matrix
Achieve scheduling attainment

Skills

Supply Chain Management

Inventory Reconciliation

Production Scheduling

Scrap Reduction

Changeover Matrix

Scheduling Attainment

Run Size Optimization

DOH Reduction

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free